Hans-Joerg Pfleiderer

Title: The Innovative Journey of Hans-Joerg Pfleiderer

Introduction

Hans-Joerg Pfleiderer, an accomplished inventor hailing from Ulm, Germany, has made significant contributions to the field of medical technology. With a robust portfolio consisting of four patents, his work primarily focuses on improving diabetes management and hormone regulation.

Latest Patents

One of Pfleiderer's latest patents details an innovative array and method for dosing a hormone that regulates blood sugar in diabetic patients. This invention seeks to enhance hormone administration, specifically insulin, through a comprehensive system comprising several key components. The system includes a first sensor designed to measure tissue glucose levels, which provides input to a controller equipped with a control algorithm. This algorithm calculates the appropriate hormone dosage based on the measured tissue glucose level.

Additionally, his invention integrates a hormone dosing unit that automatically administers the prescribed hormone based on signals from the controller. To further refine this process, a second sensor measures an influencing patient variable. This second sensor connects to a pilot control device, which optimizes the controller's responsiveness by reducing dead time, ensuring timely hormone administration.

Career Highlights

Throughout his career, Hans-Joerg Pfleiderer has made notable strides while working with prominent companies in the medical field, including Roche Diagnostics GmbH and Roche Diagnostics Operations, Inc. His work at these institutions has allowed him to develop innovative solutions that have the potential to improve patient care in diabetes management.

Collaborations

Pfleiderer's collaborative efforts have included partnerships with skilled professionals such as Ralf Gessler and Udo Hoss. These collaborations highlight the importance of teamwork in advancing medical technologies and transforming innovative ideas into practical applications.

Conclusion

With a commitment to enhancing diabetes management through innovative technologies, Hans-Joerg Pfleiderer has established himself as a valuable contributor to medical research and development. His patents serve as a testament to his expertise and dedication to improving patient outcomes in the realm of hormonal regulation.